A CRO, or contract research organization, is a company that pharmaceutical and biotech firms hire to handle some or all of the work involved in running a clinical trial. Rather than building every capability in-house, a drug developer (called the “sponsor”) contracts with a CRO to manage tasks ranging from early safety testing and regulatory filings to recruiting patients, collecting data, and monitoring trial sites. The global CRO industry is valued at roughly $92 billion in 2025 and is projected to exceed $175 billion by 2032, reflecting how central outsourcing has become to modern drug development.
Services Before the Trial Begins
CRO involvement often starts well before a single patient is enrolled. On the preclinical side, a CRO may run toxicology studies to evaluate a drug candidate’s safety, conduct pharmacokinetic studies to understand how the drug is absorbed and broken down in the body, test how the drug interacts with other medications, develop the best dosage form (tablet, injection, liquid), and perform stability testing to see how the compound holds up under different storage conditions. These steps generate the safety and manufacturing data a sponsor needs before applying to regulators for permission to test in humans.
CROs also handle analytical work like creating and validating the lab methods used to measure drug purity or track drug concentrations in blood and tissue samples. For small biotech companies that lack their own laboratories, this preclinical support can be the difference between moving a candidate forward and stalling out.
Running the Trial Day to Day
Once a trial is approved to begin, a CRO’s clinical team takes over operational management. The core services at this stage include:
- Project management: A clinical research project manager acts as the main link between the sponsor and the research team, coordinating work across multiple sites, managing budgets and timelines, overseeing drug storage and distribution, and keeping communication flowing between sponsors, investigators, and site staff.
- Site management: CRO staff oversee the day-to-day operations at each hospital or clinic participating in the trial. This includes training site personnel, managing supplies, and ensuring data quality.
- Regulatory affairs: Specialists prepare and submit the documents regulators require, then maintain compliance throughout the study.
- Medical writing: Writers produce study protocols, informed consent forms, investigator brochures, clinical study reports, and regulatory submission documents.
- Logistics: The CRO manages the supply chain for investigational products, handling shipping, storage, and tracking.
Project managers create formal communication plans that spell out how and when updates, requests, and decisions move between teams. They are also responsible for winding down a trial on schedule, guiding team members through close-out tasks and final documentation.
Monitoring Trial Sites
One of the most visible CRO roles is clinical monitoring, carried out by clinical research associates (CRAs) who physically visit or remotely review trial sites. Monitoring happens in three main phases.
During a site initiation visit, the CRA makes sure study personnel are trained on the approved protocol and regulatory requirements, reviews data collection methods, clarifies staff roles, and goes over procedures for handling samples and investigational products. This visit sets the ground rules before enrollment opens.
Routine monitoring visits happen throughout the trial. The CRA checks that the site is following the protocol, verifies that every participant signed a proper consent form, compares data recorded in case report forms against original medical records (a process called source document verification), and confirms that adverse events are being reported correctly. They also review how the investigational product is being stored, dispensed, and accounted for.
At the close-out visit, the CRA resolves any outstanding issues, verifies that all required documents are in the site’s files, confirms that leftover investigational product has been returned or destroyed, reviews how long records must be retained, and identifies a contact person in case regulators audit the site later.
Managing Trial Data
Clinical data management is a multi-step process that directly affects whether a trial’s results are trustworthy. CRO data teams design the database for the study, building in the trial’s specific visit schedules, site details, and patient identifiers. Before anyone enters data, the system goes through validation to confirm it meets security and regulatory standards.
Once data starts flowing in, the team runs automated checks (called edit checks) to catch errors and inconsistencies. Discrepancies are flagged and sent back to sites for clarification. This back-and-forth, known as discrepancy management, is considered the most critical step in cleaning up trial data and demands close attention.
When all data has been collected and cleaned, a final validation run confirms there are no remaining issues. The team then uses a pre-lock checklist to verify every data management task is complete. Once all stakeholders sign off, the database is locked. No changes can be made after locking, and the clean dataset is handed to biostatisticians for analysis. CRO statisticians then run the planned analyses that will appear in the final clinical study report and regulatory submissions.
Safety Monitoring and Reporting
Throughout a trial, CROs are responsible for pharmacovigilance: tracking and reporting adverse events and other safety signals. Every side effect a participant experiences gets documented, assessed for severity and potential connection to the study drug, and reported to regulators within required timeframes. This ongoing safety surveillance protects participants and feeds into the risk-benefit evaluation that regulators use when deciding whether to approve a treatment.
Patient Recruitment and Retention
Enrollment delays are one of the most common reasons clinical trials run over budget and behind schedule, so CROs invest heavily in recruitment and retention strategies. On the recruitment side, CROs help identify and select trial sites based on patient access, investigator experience, and operational readiness.
Retention efforts focus on keeping enrolled participants engaged for the full duration of the study. Common tools include appointment reminders via phone, email, or mailed cards; travel reimbursement and meal vouchers; regular newsletters that update participants on trial progress and educate them about their condition; and in longer studies, participant education events like cooking demonstrations or exercise programs tied to the health condition being studied. These approaches reduce dropout rates that can threaten the statistical validity of results.
Legal Responsibility and Sponsor Oversight
Under U.S. federal regulations (21 CFR 312.52), a sponsor can transfer responsibility for any or all of its regulatory obligations to a CRO, but the transfer must be documented in writing. If only some obligations are handed off, the written agreement must specify exactly which ones. Any obligation not explicitly listed stays with the sponsor. Once a CRO assumes an obligation, it is held to the same regulatory standards as the sponsor and faces the same enforcement actions for noncompliance.
International Good Clinical Practice guidelines reinforce this framework. The sponsor remains responsible for vetting the CRO’s qualifications before delegating work and for ongoing oversight afterward. If significant noncompliance is identified and the CRO fails to correct it, the sponsor is expected to consider terminating that relationship. In practice, this means CROs operate under continuous quality scrutiny, with audits verifying that trial activities were conducted and reported according to the protocol, standard operating procedures, and applicable regulations.
Full-Service vs. Functional Outsourcing
Not every sponsor hands over the entire trial. Two main outsourcing models exist. In a full-service model, a single CRO manages end-to-end trial delivery with integrated project management and one point of accountability. This is simpler to manage but gives the sponsor less direct control and can be slower to adapt when priorities shift.
In a functional service provider (FSP) model, the sponsor outsources specific roles or departments, like data management or biostatistics, while keeping overall coordination in-house. FSP staff often work within the sponsor’s own tools and systems, essentially functioning as an extension of the sponsor’s team. This gives the sponsor more control and consistency across multiple studies but requires stronger internal governance to manage the interfaces between teams. The choice between the two models usually comes down to how much oversight a sponsor wants to retain and how much internal infrastructure it already has.